Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial

Mitjà, Oriol; Corbacho‐Monné, Marc; Ubals, María; Tebé, Cristian; Peñafiel, Judith; Tobı́as, Aurelio; Ballana, Ester; Alemany, Andrea; Martí, Nuria; A. Pérez, Carla; Suñer, Clara; Laporte, Pep; Admella, Pol; Mitjà, Jordi; Clua, Mireia; Bertran, Laia; Sarquella, Maria; Gavilán, Sergi; Ara, Jordi; M. Argimón, Josep; Casabona, Jordi; Cuatrecasas, Gabriel; Paz Cañadas, M.; Elizalde‐Torrent, Aleix; Fabregat, Robert; Farré, Magı́; Forcada, Anna; Flores‐Mateo, Gemma; Muntada, Esteve; Nadal, Núria; Narejos, Silvia; Nieto, Aroa; Prat, Núria; Puig, Jordi; Quiñones, Carles; Reyes‐Urueña, Juliana; Ramírez-Viaplana, Ferran; Ruiz, Lı́dia; Riveira‐Muñoz, Eva; Sierra, Alba; Velasco, César; Maria Vivanco‐Hidalgo, Rosa; Sentís, Alexis; González-Beiras, Camila; Clotet, Bonaventura; Vall-Mayans, Martí

doi:10.1093/cid/ciaa1009

Public

Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial

Published in Clinical Infectious Diseases • Jul 13, 2020

Authors:

Oriol Mitjà

Marc Corbacho‐Monné

María Ubals

Abstract

BACKGROUND: No effective treatments for coronavirus disease 2019 (COVID-19) exist. We aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be efficacious for outpatients with COVID-19. METHODS: Multicenter open-label, randomized, controlled trial conducted in Catalonia, Spa...

Subject

Hydroxychloroquine

Medicine

Coronavirus disease 2019 (COVID-19)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!